Cargando…

High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets

CRISPR-Cas9 nucleases are widely used for genome editing but can induce unwanted off-target mutations. Existing strategies for reducing genome-wide off-targets of the broadly used Streptococcus pyogenes Cas9 (SpCas9) are imperfect, possessing only partial or unproven efficacies and other limitations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kleinstiver, Benjamin P., Pattanayak, Vikram, Prew, Michelle S., Tsai, Shengdar Q., Nguyen, Nhu, Zheng, Zongli, Joung, J. Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851738/ https://www.ncbi.nlm.nih.gov/pubmed/26735016 http://dx.doi.org/10.1038/nature16526

Ejemplares similares

Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells
por: Kleinstiver, Benjamin P., et al.
Publicado: (2016)

Engineered CRISPR-Cas9 nucleases with altered PAM specificities
por: Kleinstiver, Benjamin P., et al.
Publicado: (2015)

CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets
por: Tsai, Shengdar Q., et al.
Publicado: (2017)

GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
por: Tsai, Shengdar Q., et al.
Publicado: (2014)

In vivo CRISPR editing with no detectable genome-wide off-target mutations
por: Akcakaya, Pinar, et al.
Publicado: (2018)

The impact of nucleosome structure on CRISPR/Cas9 fidelity
por: Handelmann, Christopher R, et al.
Publicado: (2023)

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
por: Chen, Janice S., et al.
Publicado: (2017)

Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize
por: Lee, Keunsub, et al.
Publicado: (2018)

Broad Specificity Profiling of TALENs Results in Engineered Nucleases With Improved DNA Cleavage Specificity
por: Guilinger, John P., et al.
Publicado: (2014)

FrCas9 is a CRISPR/Cas9 system with high editing efficiency and fidelity
por: Cui, Zifeng, et al.
Publicado: (2022)

CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity
por: Lazzarotto, Cicera R., et al.
Publicado: (2020)

Genome-Wide Off-Target Analysis in CRISPR-Cas9 Modified Mice and Their Offspring
por: Dong, Yan, et al.
Publicado: (2019)

Revealing Off-Target Cleavage Specificities of Zinc Finger Nucleases by In Vitro Selection
por: Pattanayak, Vikram, et al.
Publicado: (2011)

High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
por: Fu, Yanfang, et al.
Publicado: (2013)

CRISPRon/off: CRISPR/Cas9 on- and off-target gRNA design
por: Anthon, Christian, et al.
Publicado: (2022)

Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023)

High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
por: Pattanayak, Vikram, et al.
Publicado: (2013)

CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
por: Brault, Julie, et al.
Publicado: (2023)

Sniper2L is a high-fidelity Cas9 variant with high activity
por: Kim, Young-hoon, et al.
Publicado: (2023)

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
por: Zhang, Xiao-Hui, et al.
Publicado: (2015)

enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9
por: Neggers, Jasper Edgar, et al.
Publicado: (2021)

Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
por: Tsai, Shengdar Q., et al.
Publicado: (2014)

Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning
por: Wang, Daqi, et al.
Publicado: (2019)

Illuminating the genome-wide activity of genome editors for safe and effective therapeutics
por: Cheng, Yong, et al.
Publicado: (2018)

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
por: György, Bence, et al.
Publicado: (2018)

Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells
por: Kaeuferle, Theresa, et al.
Publicado: (2022)

Effective use of sequence information to predict CRISPR-Cas9 off-target
por: Zhang, Zhong-Rui, et al.
Publicado: (2022)

Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods
por: Chaudhari, Hemangi G., et al.
Publicado: (2020)

COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme
por: Fasching, Clare L., et al.
Publicado: (2022)

Minimal genome-wide human CRISPR-Cas9 library
por: Gonçalves, Emanuel, et al.
Publicado: (2021)

CRISPR/Cas9-based genome-wide screening of Dictyostelium
por: Ogasawara, Takanori, et al.
Publicado: (2022)

High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells
por: Idoko-Akoh, Alewo, et al.
Publicado: (2018)

High-fidelity Glucagon-CreER mouse line generated by CRISPR-Cas9 assisted gene targeting
por: Ackermann, Amanda M., et al.
Publicado: (2017)

High levels of AAV vector integration into CRISPR-induced DNA breaks
por: Hanlon, Killian S., et al.
Publicado: (2019)

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation
por: Konstantinidis, Evangelos, et al.
Publicado: (2022)

piCRISPR: Physically informed deep learning models for CRISPR/Cas9 off-target cleavage prediction
por: Störtz, Florian, et al.
Publicado: (2023)

Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
por: Hart, Traver, et al.
Publicado: (2017)

High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis
por: Xu, Xingbo, et al.
Publicado: (2018)

Computational normal mode analysis accurately replicates the activity and specificity profiles of CRISPR-Cas9 and high-fidelity variants
por: Shor, Oded, et al.
Publicado: (2022)

Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9
por: Koo, Taeyoung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_865fa0dm4ji1bdek56r0g21iss